MedPath

EMBODY ORTHOPAEDIC LIMITED

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement

Not Applicable
Not yet recruiting
Conditions
Inflammatory Arthritis
Osteoarthritis, Hip
Interventions
Device: The H1 Implant
Device: Cementless total hip replacement
First Posted Date
2023-12-08
Last Posted Date
2023-12-08
Lead Sponsor
Embody Orthopaedic Limited
Target Recruit Count
200
Registration Number
NCT06162195

H1 Hip Resurfacing Arthroplasty

Active, not recruiting
Conditions
Hip Necrosis
Hip Dysplasia
Hip Osteoarthritis
Interventions
Device: H1 Hip Resurfacing Arthroplasty
First Posted Date
2017-10-31
Last Posted Date
2023-09-07
Lead Sponsor
Embody Orthopaedic Limited
Target Recruit Count
250
Registration Number
NCT03326804
Locations
🇬🇧

Kind Edward VII's Hospital, London, United Kingdom

🇬🇧

Charing Cross Hospital, London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath